
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Beyond the aerospace and automotive sectors, medical uses for carbon fiber reinforced polymers (CFRPs) are proliferating. In lieu of conventional metal-based medical implants, CFRP-based materials are becoming more popular due to their high strength-to-weight ratio, lightness, and radiolucency.
Within orthopaedic surgery, carbon fiber implants are being used more frequently in a variety of fields, such as spinal, trauma, arthroplasty, and oncology.
The Global Carbon fiber medical implant market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Invibio, a provider of biomaterial solutions to the medical device market, has announced the launch of ENDOLIGN composite, a new biocompatible carbon fibre-reinforced thermoplastic material for use in implantable load bearing medical device applications requiring blood, bone or tissue contact of more than 30 days.
The ENDOLIGN composite and process present the first non-metallic biomaterial for use in medical implants that combines the high strength of metals with the comprehensive biocompatibility and imaging compatibility of polymers.
The results of ENDOLIGN composite's biocompatibility testing show that it meets or surpasses the requirements of ISO 10993 standards for long-term implantable medical devices.
High amounts of continuous carbon fibres are combined with a PEEK-OPTIMA polymer matrix and are pre-impregnated into a tape to create ENDOLIGN, which is produced to ISO 9001 quality standards.Once moulded, this tape can be made into poles or other shapes.
When tested in moulded unidirectional rod form, the material's flexural strength increased from about 150 MPa for PEEK-OPTIMA polymer to more than 1000 MPa, and its stiffness increased from 3.5GPa to 150GPa.
These changes are a result of the continuous carbon fibres, which greatly improve the material's mechanical properties. Manufacturers of medical equipment will be able to create a new generation of implants with enhanced imaging capabilities and increased strength thanks to ENDOLIGN composite.
Due to its exceptional characteristics, ENDOLIGN is perfectly suitable for the creation of long-term implantable load bearing medical device applications.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |